Evolent Health (EVH)
(Delayed Data from NYSE)
$9.98 USD
-0.07 (-0.70%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $9.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EVH 9.98 -0.07(-0.70%)
Will EVH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EVH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EVH
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
EVH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Q1 Earnings Lag Estimates
Other News for EVH
Truist Securities Raises Price Target for Evolent Health (EVH) | EVH Stock News
Evolent Health (EVH) Target Price Increased as Analyst Remains Positive | EVH Stock News
Evolent Health price target raised by $2 at Truist, here's why
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts
Evolent Health Inc (EVH) Announces Upcoming Financial Results Release and Conference ...